STOCK TITAN

RxSight (RXST) CCO gains 6,261 shares, withholds 2,580 for taxes

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

RxSight, Inc. Chief Customer Officer Scott Gaines reported multiple equity transactions. On February 27, 2026, he received a grant of 32,218 restricted stock units (RSUs), each representing one share of common stock, subject to multi‑year service-based vesting. On February 28, 2026, several RSU awards vested and were exercised, resulting in the acquisition of 6,261 shares of common stock at a stated price of $0.00 per share. On the same date, 2,580 shares of common stock were disposed of at $7.61 per share to cover tax withholding obligations. After these transactions, Gaines directly owned 14,848 shares of RxSight common stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gaines Scott

(Last) (First) (Middle)
100 COLUMBIA

(Street)
ALISO VIEJO CA 92656

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
RxSight, Inc. [ RXST ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Customer Officer
3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/28/2026 M 6,261 A (1) 17,428 D
Common Stock 02/28/2026 F 2,580 D $7.61 14,848 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit (1) 02/27/2026 A 32,218 (2) (2) Common Stock 32,218 $0 32,218 D
Restricted Stock Unit (1) 02/28/2026 M 1,500 (3) (3) Common Stock 1,500 $0 3,000 D
Restricted Stock Unit (1) 02/28/2026 M 604 (4) (4) Common Stock 604 $0 2,414 D
Restricted Stock Unit (1) 02/28/2026 M 1,250 (5) (5) Common Stock 1,250 $0 6,250 D
Restricted Stock Unit (1) 02/28/2026 M 1,657 (6) (6) Common Stock 1,657 $0 9,936 D
Restricted Stock Unit (1) 02/28/2026 M 1,250 (7) (7) Common Stock 1,250 $0 2,500 D
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
2. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan (the "Plan")) through each applicable date, one-sixth (1/6th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028 and February 28, 2029.
3. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Plan) through each applicable date, one-eighth (1/8th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2023, February 29, 2024, August 31, 2024, February 28, 2025, August 31, 2025, February 28, 2026, August 31, 2026 and February 28, 2027. Of the 12,000 RSUs initially subject to the award, 7,500 shares subject to the award vested prior to the Reporting Person becoming a Section 16 executive officer.
4. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Plan) through each applicable date, one-eighth (1/8th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2024, February 28, 2025, August 31, 2025, February 28, 2026, August 31, 2026, February 28, 2027, August 31, 2027 and February 29, 2028. Of the 4,830 RSUs initially subject to the award, 1,812 shares subject to the award vested prior to the Reporting Person becoming a Section 16 executive officer.
5. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Plan) through each applicable date, one-eighth (1/8th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of February 28, 2025, August 31, 2025, February 28, 2026, August 31, 2026, February 28, 2027, August 31, 2027, February 29, 2028 and August 31, 2028. Of the 10,000 RSUs initially subject to the award, 2,500 shares subject to the award vested prior to the Reporting Person becoming a Section 16 executive officer.
6. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Plan) through each applicable date, one-eighth (1/8th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2025, February 28, 2026, August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028 and February 28, 2029. Of the 13,250 RSUs initially subject to the award, 1,657 shares subject to the award vested prior to the Reporting Person becoming a Section 16 executive officer.
7. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Plan) through each applicable date, one-fourth (1/4th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2025, February 28, 2026, August 31, 2026, February 28, 2027. Of the 5,000 RSUs initially subject to the award, 1,250 shares subject to the award vested prior to the Reporting Person becoming a Section 16 executive officer.
Remarks:
Exhibit 24 - Power of Attorney
/s/ Jim Schindler, as Attorney-in-Fact 03/03/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did RxSight (RXST) Chief Customer Officer report?

Scott Gaines reported a new grant of 32,218 restricted stock units and multiple RSU exercises on February 27–28, 2026. These exercises delivered 6,261 common shares, with 2,580 shares withheld at $7.61 each to satisfy tax obligations under the equity plan.

How many restricted stock units did Scott Gaines receive from RxSight (RXST)?

Scott Gaines received a grant of 32,218 restricted stock units, each representing one share of RxSight common stock. The award vests over several dates between August 31, 2026 and February 28, 2029, contingent on his continued service under the company’s 2021 Equity Incentive Plan.

How many RxSight (RXST) shares did Scott Gaines acquire and dispose in this Form 4?

Through RSU exercises, Scott Gaines acquired 6,261 shares of RxSight common stock at a stated price of $0.00 per share. He also disposed of 2,580 shares at $7.61 per share, with those shares used to pay tax liabilities related to the equity vesting.

What is Scott Gaines’ direct ownership in RxSight (RXST) after these transactions?

Following the reported Form 4 transactions, Scott Gaines directly held 14,848 shares of RxSight common stock. This figure reflects shares acquired from restricted stock unit exercises, net of the 2,580 shares withheld and delivered to cover associated tax obligations on February 28, 2026.

How do Scott Gaines’ RxSight (RXST) RSUs vest over time?

The RSU awards vest in installments on specified trading days, generally in eighths or sixths over scheduled dates from August 31, 2023 through February 28, 2029. Vesting requires Gaines to remain a Service Provider under RxSight’s 2021 Equity Incentive Plan through each applicable date.

What does the tax withholding transaction in RxSight (RXST) Form 4 represent?

The tax withholding transaction shows 2,580 RxSight common shares disposed at $7.61 per share. These shares were delivered to satisfy tax liabilities triggered by the vesting and exercise of restricted stock units, rather than being an open-market sale initiated for investment purposes.
Rxsight, Inc.

NASDAQ:RXST

RXST Rankings

RXST Latest News

RXST Latest SEC Filings

RXST Stock Data

322.29M
38.53M
Medical Devices
Ophthalmic Goods
Link
United States
ALISO VIEJO